Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein 65 (HSP65) from *Mycobacterium bovis* is a highly conserved molecular chaperone that protects cells against stress. It's an immunodominant antigen recognized by the host immune system and plays a role in both protective immunity against tuberculosis and potentially in autoimmunity. Expression increases upon stress and it is involved in TLR4 signaling. Primarily studied as a vaccine target and for immunological research.
Not applicable; target is not directly drug-targeted but used in vaccine research and immunological studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat Shock Protein 65 (Mycobacterium bovis) (HSP65).